Veracyte, Inc.
VCYT
Rank in Stocks
#4417
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Share Price
$44.31
Market Cap
$3.56B
Change (1 day)
1.16%
Change (1 year)
20.89%
Country
US
Trade Veracyte, Inc. (VCYT)
Category
Healthcare
Stock split history for Veracyte, Inc. (VCYT)
Veracyte, Inc. stock (symbol: VCYT) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One VCYT share bought prior to Oct 20, 2026 would equal to 0 VCYT shares today.
The most recent stock split occurred on Oct 20, 2026.
One VCYT share bought prior to Oct 20, 2026 would equal to 0 VCYT shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
